Illinois 104th General Assembly Status: Introduced 19 D cosponsors

SB0066      — HEALTH CARE AVAILABILITY

Last action — Senate Committee Amendment No. 4 Rule 3-9(a) / Re-referred to Assignments

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced January 13, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Not enough signal yet

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

In plain language

Establishes a board to manage prescription drug costs in the State.

The bill creates the Health Care Availability and Access Board to oversee and limit prescription drug prices based on Medicare rates. Additionally, it forms a Stakeholder Council for input in decision-making.

What this means for you
  • Families: Families may benefit from lower prescription drug costs due to the Board's regulation of prices based on Medicare rates.
  • Healthcare: The Board will set payment limits on prescription drugs, potentially making medications more affordable for healthcare providers and their patients.
  • Small Business: Small businesses may experience reduced costs related to employee healthcare as the Board aims to lower prescription drug prices.

Summary

Creates the Health Care Availability and Access Board Act. Establishes the Health Care Availability and Access Board to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains provisions concerning Board membership and terms; staff for the Board; Board meetings; circumstances under which Board members must recuse themselves; and other matters. Provides that the Board shall perform the following actions in open session: (i) deliberations on whether to subject a prescription drug product to a cost review; and (ii) any vote on whether to impose an upper payment limit on purchases, payments, and payor reimbursements of prescription drug products in the State. Permits the Board to adopt rules to implement the Act and to enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the Board. Creates the Health Care Availability and Access Stakeholder Council to provide stakeholder input to assist the Board in making decisions as required by the Act. Contains provisions concerning Council membership, member terms, and other matters. Provides that the Board shall adopt the federal Medicare Maximum Fair Price as the upper payment limit for a prescription drug product intended for use by individuals in the State. Prohibits the Board from creating an upper payment limit that is different from the Medicare Maximum Fair Price for the prescription drug product that has a Medicare Maximum Fair Price. Requires the Board to implement an upper payment limit that is the same as the Medicare Maximum Fair Price no sooner than the Medicare implementation date. Provides that Medicare Part C and D plans are not required to reimburse at the upper payment limit. Provides that the Attorney General may enforce the Act and may pursue any available remedy under State law when enforcing the Act. Effective 180 days after becoming law.

Bill Text

We don't have the full text on file for this bill yet.

Read SB0066 on the official Illinois source →

Action History

  1. Senate Committee Amendment No. 4 Rule 3-9(a) / Re-referred to Assignments

  2. Senate Committee Amendment No. 3 Rule 3-9(a) / Re-referred to Assignments

  3. Senate Committee Amendment No. 2 Rule 3-9(a) / Re-referred to Assignments

  4. Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments

  5. Rule 3-9(a) / Re-referred to Assignments

  6. Rule 2-10 Committee/3rd Reading Deadline Established As May 22, 2026

  7. Added as Co-Sponsor Sen. Lakesia Collins

  8. Senate Committee Amendment No. 4 Assignments Refers to Executive

  9. Rule 2-10 Committee/3rd Reading Deadline Established As May 15, 2026

  10. Added as Co-Sponsor Sen. Mattie Hunter

  11. Added as Co-Sponsor Sen. Napoleon Harris III

  12. Senate Committee Amendment No. 3 Assignments Refers to Executive

  13. Senate Committee Amendment No. 2 Assignments Refers to Executive

  14. Senate Committee Amendment No. 4 Referred to Assignments

  15. Senate Committee Amendment No. 4 Filed with Secretary by Sen. Graciela Guzmán

  16. Senate Committee Amendment No. 3 Referred to Assignments

  17. Senate Committee Amendment No. 3 Filed with Secretary by Sen. Graciela Guzmán

  18. Senate Committee Amendment No. 2 Referred to Assignments

  19. Senate Committee Amendment No. 2 Filed with Secretary by Sen. Graciela Guzmán

  20. Rule 2-10 Committee Deadline Established As April 24, 2026

  21. Senate Committee Amendment No. 1 Assignments Refers to Executive

  22. Rule 2-10 Committee Deadline Established As March 27, 2026

  23. Senate Committee Amendment No. 1 Referred to Assignments

  24. Senate Committee Amendment No. 1 Filed with Secretary by Sen. Graciela Guzmán

  25. Assigned to Executive

  26. Added as Co-Sponsor Sen. Javier L. Cervantes

  27. Added as Chief Co-Sponsor Sen. Robert Peters

  28. Chief Sponsor Changed to Sen. Graciela Guzmán

  29. Added as Co-Sponsor Sen. Doris Turner

  30. Added as Co-Sponsor Sen. Kimberly A. Lightford

  31. Added as Co-Sponsor Sen. Mark L. Walker

  32. Added as Co-Sponsor Sen. Celina Villanueva

  33. Added as Co-Sponsor Sen. Christopher Belt

  34. Added as Chief Co-Sponsor Sen. Graciela Guzmán

  35. Added as Chief Co-Sponsor Sen. Karina Villa

  36. Added as Chief Co-Sponsor Sen. Mike Simmons

  37. Added as Co-Sponsor Sen. Laura M. Murphy

  38. Added as Chief Co-Sponsor Sen. David Koehler

  39. Added as Co-Sponsor Sen. Mike Porfirio

  40. Added as Co-Sponsor Sen. Rachel Ventura

  41. Added as Co-Sponsor Sen. Mary Edly-Allen

  42. Added as Co-Sponsor Sen. Michael W. Halpin

  43. Referred to Assignments

  44. First Reading

  45. Filed with Secretary by Sen. Robert Peters

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 18 co-sponsors · 164 not signed on

Sponsors (1)

Co-sponsors (18)

Not signed on (164)

164 members have not signed on to this bill.

Show all 164 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB0066      do?
Creates the Health Care Availability and Access Board Act. Establishes the Health Care Availability and Access Board to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains provisions concerning Board membership and terms; staff for the Board; Board meetings; circumstances under which Board members must recuse themselves; and other matters. Provides that the Board shall perform the following actions in open session: (i) deliberations on whether to subject a prescription drug product to a cost review; and (ii) any vote on whether to impose an upper payment limit on purchases, payments, and payor reimbursements of prescription drug products in the State. Permits the Board to adopt rules to implement the Act and to enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the Board. Creates the Health Care Availability and Access Stakeholder Council to provide stakeholder input to assist the Board in making decisions as required by the Act. Contains provisions concerning Council membership, member terms, and other matters. Provides that the Board shall adopt the federal Medicare Maximum Fair Price as the upper payment limit for a prescription drug product intended for use by individuals in the State. Prohibits the Board from creating an upper payment limit that is different from the Medicare Maximum Fair Price for the prescription drug product that has a Medicare Maximum Fair Price. Requires the Board to implement an upper payment limit that is the same as the Medicare Maximum Fair Price no sooner than the Medicare implementation date. Provides that Medicare Part C and D plans are not required to reimburse at the upper payment limit. Provides that the Attorney General may enforce the Act and may pursue any available remedy under State law when enforcing the Act. Effective 180 days after becoming law.
Who sponsors SB0066     ?
SB0066      is sponsored by Graciela Guzmán (Democrat), David Koehler (Democrat), Mike Simmons (Democrat), Karina Villa (Democrat), Robert Peters (Democrat), Michael W. Halpin (Democrat), Mary Edly-Allen (Democrat), Rachel Ventura (Democrat), Mike Porfirio (Democrat), Laura M. Murphy (Democrat), Christopher Belt (Democrat), Celina Villanueva (Democrat), Mark L. Walker (Democrat), Kimberly A. Lightford (Democrat), Doris Turner (Democrat), Javier L. Cervantes (Democrat), Napoleon Harris III (Democrat), Mattie Hunter (Democrat), and Lakesia Collins (Democrat).
What is the current status of SB0066     ?
This bill has been introduced in the Senate. Introduced January 13, 2025. It must pass committee before a floor vote.
Where can I track SB0066     ?
Track SB0066      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB0066     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB0066     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →